| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0002-1220-50 | 0002-1220 | HUMAN PRESCRIPTION DRUG | TAUVID | Flortaucipir F-18 | INJECTION, SOLUTION | INTRAVENOUS | 20221025 | N/A | NDA | NDA212123 | Eli Lilly and Company | FLORTAUCIPIR F-18 | 100 mCi/mL | 1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-50) / 50 mL in 1 VIAL, MULTI-DOSE |
| 0002-1220-48 | 0002-1220 | HUMAN PRESCRIPTION DRUG | TAUVID | Flortaucipir F-18 | INJECTION, SOLUTION | INTRAVENOUS | 20221025 | N/A | NDA | NDA212123 | Eli Lilly and Company | FLORTAUCIPIR F-18 | 100 mCi/mL | 1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-48) / 100 mL in 1 VIAL, MULTI-DOSE |